Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COLONIC RESECTION FOR CANCER AS DIABETOGENIC RISK FACTOR - A Study of the Pathophysiological Effects of Colon Resection on Glucose Homeostasis

NCT04649567 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT04649567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04649567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COLONIC RESECTION FOR CANCER AS DIABETOGENIC RISK FACTOR - A Study of the Pathophysiological Effects of Colon Resection on Glucose Homeostasis
Lead sponsor
Hvidovre University Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 10, 2020
Completion date
August 31, 2023
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, colon cancer, glucose metabolism disorders, surgery